Methyldopa: physicochemical characterization of the erythrocyte autoantibody.

Erythrocyte autoantibody associated with alpha-methyldopa: heterogeneity of structure and specificity.

The Morphological Characterization of the Blood Cells in the Central Asian Tortoise (Testudo horsfieldii)

In this study morphological characterization of leukocyte and erythrocyte were investigated in central Asian tortoise (Testudo horsfieldii) in Iran. 7 males and 7 females were used in this study. Erythrocyte and leukocyte morphology were described using Wright´s technique. The sizes of erythrocyte and their nuclei were measured using an ocular micrometer under objective lenses (100x). Resul...

Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody

By generating four IgG isotype-switch variants of the high affinity 34-3C anti-erythrocyte autoantibody, and comparing them to the IgG variants of the low affinity 4C8 anti-erythrocyte autoantibody that we have previously studied, we evaluated in this study how high affinity binding to erythrocytes influences the pathogenicity of each IgG isotype in relation to the respective contributions of F...

Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.

Major histocompatibility (MHC) class II molecules are strongly associated with many autoimmune disorders. In type 1 diabetes (T1D), the DQ8 molecule is common, confers significant disease risk, and is involved in disease pathogenesis. We hypothesized that blocking DQ8 antigen presentation would provide therapeutic benefit by preventing recognition of self-peptides by pathogenic T cells. We used...

Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar

Background: Etanercept is prescribed for the rapid and effective treatment of chronic immune-mediated inflammatory disorders. Due to the expiration of etanercept patents and worldwide demand for comparable and more affordable substitutes, several biosimilars of etanercept have been approved in different countries and new ones are in the process of approval.Objectives: In the present study...